<DOC>
	<DOC>NCT00371007</DOC>
	<brief_summary>A clinical study to determine the safety and efficacy of MK-0431 in patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy</brief_summary>
	<brief_title>MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients have type 2 diabetes mellitus On diet/exercise therapy Patients have type 1 diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>